Conference on Innovative Financial Solutions for Development

in page functions

IFFIm and AMC standout products at Marketplace for Innovative Financial Solutions for Development

Paris, 4-5 March 2010 - GAVI's trademark innovative approach to funding immunisation was put on show at the Marketplace for Innovative Financial Solutions in Paris this week.

Both the International Finance Facility for Immunisation (IFFIm) and the Advance Market Commitment (AMC) received front-row attention throughout the two-day conference, with Robert Zoellick, President of the World Bank, singling out both initiatives as among the "most encouraging" examples of innovative thinking in financing development.

Innovative financing is a simple idea, now becoming reality.

Bernard Kouchner, France's Foreign Affairs Minister


Hosted by the Agence Française de Développement (AFD), the Bill & Melinda Gates Foundation and the World Bank, the Marketplace brought together hundreds of development practitioners from around the world to discuss fresh ideas on financial solutions for development.

"There is a crucial need to find additional financing and increase innovation in order to maintain momentum toward achieving the Millennium Development Goals. Innovative financing is a simple idea, now becoming reality," said France's Foreign Affairs Minister Bernard Kouchner in his opening remarks to the conference.

"France plays a key leadership role in innovative financing, illustrated by its strong involvement in the successful International Finance Facility for Immunisation," added Kouchner. France is the second biggest donor to the IFFIm after the UK, committing €1.2 billion to the table.

Referring to the IFFIm, Jean-Michel Severino, head of Agence Française de Développement (AFD), noted that GAVI was among the good examples of increasing predictability of development co-operation and reducing risks for developing countries.

US$ 1 = US$ 18

A study in Health Affairs covering 73 Gavi-supported countries over the 2011–2020 period shows that, for every US$ 1 spent on immunisation, US$ 18 are saved in healthcare costs, lost wages and lost productivity due to illness. If we take into account the broader benefits of people living longer, healthier lives, the return on investment rises to US$ 48 per US$ 1 spent.

Ozawa S, Clark S, Portnoy A et al. Return on investment from childhood immunizations in low- and middle-income countries, 2011-20, Health Affairs 2016

More facts...

close icon

modal window here